Catia Bigazzi
- Genetics top 5%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Oncology
- Molecular Biology
- Co-authors
- Piero GalieniGiuseppe MarottaAlessandro BucalossiFrancesco LauriaMonica BocchiaMonica TozziDonatella RaspadoriGiulia Scalia
- Topics
- Chronic Lymphocytic Leukemia Research (8 papers)Lymphoma Diagnosis and Treatment (8 papers)Immunodeficiency and Autoimmune Disorders (4 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBritish Journal of Haematology
In The Last Decade
Catia Bigazzi
14 papers receiving 353 citations
Peers
Comparison fields: 5 of 40
- Genetics 184
- Hematology 181
- Pathology and Forensic Medicine 148
- Oncology 121
- Molecular Biology 85
Countries citing papers authored by Catia Bigazzi
This map shows the geographic impact of Catia Bigazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catia Bigazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catia Bigazzi more than expected).
Fields of papers citing papers by Catia Bigazzi
This network shows the impact of papers produced by Catia Bigazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catia Bigazzi. The network helps show where Catia Bigazzi may publish in the future.
Co-authorship network of co-authors of Catia Bigazzi
This figure shows the co-authorship network connecting the top 25 collaborators of Catia Bigazzi. A scholar is included among the top collaborators of Catia Bigazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catia Bigazzi. Catia Bigazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 19 | |
| 4 | 45 | |
| 5 | 27 | |
| 6 | 6 | |
| 7 | 34 | |
| 8 | 40 | |
| 9 | 21 | |
| 10 | Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy. | 41 |
| 11 | Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas. | 12 |
| 12 | CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland. | 12 |
| 13 | 6 | |
| 14 | Localized orbital lymphoma. | 49 |
| 15 | 54 | |
| 16 | 11q- and constitutional X trisomy in a patient with M5b acute non-lymphocytic leukemia. | 1 |
About Catia Bigazzi
Catia Bigazzi is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 16 papers that have together received 368 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). The work is most often cited by research in Genetics (184 citations), Hematology (181 citations) and Pathology and Forensic Medicine (148 citations). Catia Bigazzi has collaborated with scholars based in Italy and Lebanon. Frequent co-authors include Piero Galieni, Giuseppe Marotta, Alessandro Bucalossi, Francesco Lauria, Monica Bocchia, Monica Tozzi, Giuseppe Marotta, Donatella Raspadori, Giulia Scalia and F. Lauria. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.